🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Turja Chakrabarti

ORCID: 0000-0002-2966-3102

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study”.

Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study

Journal of Clinical Oncology(2024)10.1200/jco.24.00071

N/A

1.4DataRank · unranked

60 citations

Anatoly Urisman, Matthew A. Gubens, Claire K. Mulvey, Greg M. Allen, Stephen Shiboski +19 more

Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.06.007

N/A

0.354DataRank · unranked

9 citations

Shigeki Nanjo, Shinji Takeuchi, Turja Chakrabarti, Tyiesha Brown, Sharon Wesley Dev Sahadevan +11 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0DataRank · unranked

186 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.12.584638

N/A

0DataRank · unranked

3 citations

Philippe Gui, Wei Wu, D. Lucas Kerr, Lisa Tan, Dora Barbosa +10 more